Detalles de la búsqueda
1.
Impact of Daptomycin Dose Exposure Alone or in Combination with ß-Lactams or Rifampin against Vancomycin-Resistant Enterococci in an In Vitro Biofilm Model.
Antimicrob Agents Chemother
; 64(5)2020 04 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-32094136
2.
Evaluation of dalbavancin alone and in combination with ß-lactam antibiotics against resistant phenotypes of Staphylococcus aureus.
J Antimicrob Chemother
; 74(1): 82-86, 2019 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30260409
3.
Combination of Tedizolid and Daptomycin against Methicillin-Resistant Staphylococcus aureus in an In Vitro Model of Simulated Endocardial Vegetations.
Antimicrob Agents Chemother
; 62(5)2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29530843
4.
ß-Lactamase Inhibitors Enhance the Synergy between ß-Lactam Antibiotics and Daptomycin against Methicillin-Resistant Staphylococcus aureus.
Antimicrob Agents Chemother
; 61(1)2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27821441
5.
Evaluation of daptomycin combinations with cephalosporins or gentamicin against Streptococcus mitis group strains in an in vitro model of simulated endocardial vegetations (SEVs).
J Antimicrob Chemother
; 72(8): 2290-2296, 2017 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28475731
6.
Oritavancin Combinations with ß-Lactams against Multidrug-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci.
Antimicrob Agents Chemother
; 60(4): 2352-8, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26833159
7.
Daptomycin in Combination with Ceftolozane-Tazobactam or Cefazolin against Daptomycin-Susceptible and -Nonsusceptible Staphylococcus aureus in an In Vitro, Hollow-Fiber Model.
Antimicrob Agents Chemother
; 60(7): 3970-5, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27090172
8.
Evaluation of tedizolid against Staphylococcus aureus and enterococci with reduced susceptibility to vancomycin, daptomycin or linezolid.
J Antimicrob Chemother
; 71(1): 152-5, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26476277
9.
Telavancin demonstrates activity against methicillin-resistant Staphylococcus aureus isolates with reduced susceptibility to vancomycin, daptomycin, and linezolid in broth microdilution MIC and one-compartment pharmacokinetic/pharmacodynamic models.
Antimicrob Agents Chemother
; 59(9): 5529-34, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26124162
10.
ß-Lactams enhance daptomycin activity against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium in in vitro pharmacokinetic/pharmacodynamic models.
Antimicrob Agents Chemother
; 59(5): 2842-8, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25753639
11.
Evaluation of Ceftaroline Alone and in Combination against Biofilm-Producing Methicillin-Resistant Staphylococcus aureus with Reduced Susceptibility to Daptomycin and Vancomycin in an In Vitro Pharmacokinetic/Pharmacodynamic Model.
Antimicrob Agents Chemother
; 59(8): 4497-503, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-25987623
12.
Impact of the combination of daptomycin and trimethoprim-sulfamethoxazole on clinical outcomes in methicillin-resistant Staphylococcus aureus infections.
Antimicrob Agents Chemother
; 59(4): 1969-76, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25605354
13.
ß-Lactam combinations with daptomycin provide synergy against vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.
J Antimicrob Chemother
; 70(6): 1738-43, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25645208
14.
A lipoglycopeptide antibiotic for Gram-positive biofilm-related infections.
Sci Transl Med
; 14(662): eabj2381, 2022 09 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36103517
15.
New Guidelines Endorse Old Recommendations for Invasive Enterococcal Infections.
Clin Infect Dis
; 63(2): 281-2, 2016 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-27161781
16.
Biofilm Time-Kill Curves to Assess the Bactericidal Activity of Daptomycin Combinations against Biofilm-Producing Vancomycin-Resistant Enterococcus faecium and faecalis.
Antibiotics (Basel)
; 10(8)2021 Jul 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-34438947
17.
Imipenem-Cilastatin-Relebactam: A Novel ß-Lactam-ß-Lactamase Inhibitor Combination for the Treatment of Multidrug-Resistant Gram-Negative Infections.
Pharmacotherapy
; 40(4): 343-356, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32060929
18.
A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections.
Infect Dis Ther
; 9(1): 89-106, 2020 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-31983021
19.
Parenteral Fosfomycin for the Treatment of Multidrug Resistant Bacterial Infections: The Rise of the Epoxide.
Pharmacotherapy
; 39(11): 1077-1094, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31487056
20.
Impact of a pharmacist-driven care package on Staphylococcus aureus bacteremia management in a large community healthcare network: A propensity score-matched, quasi-experimental study.
Diagn Microbiol Infect Dis
; 90(1): 50-54, 2018 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-29153470